StockWatch
·

Krystal Integrated Services Ltd Q2 FY27 Results

KRYSTALQ2 FY27 Results
Filing
Result:Good· Market: Flat#Margin squeeze#Cost led

Outlook: Optimistic · Guidance: None

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue414.4714.9%46.3%
Total Income419.8114.7%45.8%
Expenditure398.4615.4%46.4%
PBT21.353.2%35.1%
Net Profit18.717.5%42.1%
OPM6.00%0.32pp0.32pp
NPM4.46%0.30pp0.11pp
EPS13.397.5%42.1%
View full financials

Revenue/PAT growth of 46%/42% beat management's >20% guidance for the Industrials/manpower-services core, but operating and net margins compressed YoY and QoQ as employee costs (+53%) outpaced revenue, so the quality is capped below very_good.

KRYSTAL · Q2 FY27 · THE VERDICT

46% Growth, 32-Basis-Point Margin Squeeze—Execution Meets Headwinds

Krystal delivered 46% revenue growth, crushing its 20% prior guidance. Yet operating margins compressed 32 basis points, contradicting management's promised 'margin appreciation.' The quarter reveals a company scaling faster than its cost structure can absorb—and the debate is whether that's temporary onboarding friction or structural.

06 Nov 2026 · 6 min read
Q2 Revenue

414.5 Cr

+46.2% YoY, +14.9% QoQ

Q2 PAT

18.7 Cr

+42.1% YoY

Q2 OPM

6.0%

-32 bps vs. Q2 FY26

H1 Revenue

775.2 Cr

+27.8% YoY

Krystal's Q2 was a study in contradiction: headline numbers soared, but the profit engine sputtered. Revenue jumped 46% to ₹414.5 Cr, obliterating the prior guidance of 20%+ growth. But operating margin compressed 32 basis points (6.32% to 6.0%), despite a robust order book and 59 new corporate customer additions in the half. The street braced for margin expansion; instead, it got margin squeeze—a gap that defines the quarter.

Where the margin went

Employee costs are the culprit. In Q2, they hit 79.75% of revenue, up from 72.3% a year ago—a 750-basis-point structural shift. Management frames this as temporary onboarding cost for new contracts, which later streamline. But on the call, they didn't retreat from the assertion; they doubled down on it as deliberate strategy to capture corporate segment share. The arithmetic is clear: hire now to serve new contracts, streamline later as they ramp. The risk is whether 'later' arrives before wage inflation erodes margins further.

The initial investment done in that phase to stabilize the contract... attracts a little more working capital and other expenses than you do it on a normal month-to-month regular basis. Therefore, every quarter that you see that we sign up a new contract, you see a little dip in the margin.

What held up, what didn't

Management's key claims vs. the delivered numbers

46% YoY revenue growth with 42% PAT growth

Q2 revenue +46.2% YoY; PAT +42.1% YoY. H1 revenue +27.8% YoY.

Supported

Margin expansion in FY27 (from prior calls)

Q2 OPM 6.0% vs. 6.32% YoY (-32 bps). EBITDA margin 6% vs. 6.32% YoY.

Contradicted

59 new corporate customers in H1; corporate mix 35%

31 in Q2, 59 in H1. Corporate revenue now 35% vs. 30% baseline.

Supported

Order book Rs. 3,100 Cr provides 3–5 year runway

Order book ₹3,100 Cr; tender pipeline ₹12,000 Cr evaluated, ₹4,500 Cr bid.

Supported

Citelum to generate ₹300–350 Cr revenue in 3–4 years

Acquisition complete; team integrated; bidding active. Rs. 100 Cr capex planned.

Supported (execution pending)

Margin compression is temporary, driven by new-contract onboarding

Employee costs 79.75% of revenue. Management confident in recovery but no recovery timeline.

Partial (timing vague)

What changed this quarter vs. prior calls

  • Corporate customer expansion accelerating—59 additions in H1 vs. prior ~20/quarter trend

  • Citelum acquisition now with quantified 3–4 year revenue target (₹300–350 Cr) and active bidding

  • Margin guidance downgraded—forward target 6.25–7.5%, putting Q2 (6.0%) at bottom of range

  • Employee cost structure shifted 750 bps higher; framed as temporary but appearing structural

  • Order book stable at ₹3,100 Cr; tender pipeline ₹12,000 Cr evaluated, ₹4,500 Cr bid

The bull-bear ledger

Two-sided case
  • Revenue growth of 46% crushes prior guidance—execution is real

  • 59 new corporate customers in H1; corporate mix now 35%—shift from lower-margin government bias working

  • Order book ₹3,100 Cr with 3–5 year visibility; tender pipeline ₹12,000 Cr—revenue visibility is robust

  • Citelum acquisition on track; asset-light model de-risks execution

  • Margin compressed 32 bps despite 46% revenue growth—operational leverage not materializing

  • Employee costs 79.75% of revenue; government mix still 65%—structural headwinds to PAT growth

  • Forward margin guidance (6.25–7.5%) is a range, not a target—suggests management caution

  • Labor cost inflation (new statutory codes Nov 2025) not yet fully priced into contracts

How the street is positioned

The stock stands at ₹623, neutral in trend, -39% from its all-time high of ₹1,021.95 but +24.6% off its 52-week low. Volume is normal; RSI 56.1 is neutral. This is a stock caught in limbo—punished for missing margin guidance but not rewarded enough for beating revenue. FII ownership ticked up to 1.77% (from 1.25% last quarter), a signal of cautious buying, while DII remains flat at 3.76%. Promoter ownership is stable at 69.96%, suggesting no insider concern. Bulk deal activity over the past 6 months shows mixed conviction: RADIANT COMPUTECH bought 1,15,766 shares at ₹683.80 (above current price), suggesting confidence at higher levels, but JAGID VANITABEN has bid and reversed positions—typical of informed players hedging near-term uncertainty. The price action reflects the core debate: Is this margin pressure temporary, or will it persist?

Risks, ranked by holder concern

What should concern a long-term holder most

Operational leverage delay

Medium

46% revenue growth did not lift margins—PAT growth (42%) will lag revenue growth if costs stay elevated. If employee cost inflation outpaces contract streamlining, PAT could decelerate sharply.

Government receivables cycle

Medium

65% of revenue from government; trade receivable days at 118. Net debt ₹63.84 Cr indicates working capital strain. Government payment delays extend cash conversion cycle and increase reliance on borrowing.

Statutory labor cost recovery

Medium

India's four labor codes (effective Nov 2025) impose new statutory costs. Company is in discussions with customers, but timing and scope of recovery are unclear. If recovery is delayed, margins stay compressed.

Citelum execution

Medium

₹300–350 Cr revenue target over 3–4 years is ambitious. Market for city lighting is emerging; tender wins are uncertain. Execution miss would undermine long-term margin expansion thesis.

Tender conversion and order book quality

Low

Historical conversion rate is 8–10%. ₹12,000 Cr pipeline evaluated, ₹4,500 Cr bid. No assurance current pipeline converts at higher rates. Quality (corporate vs. government mix) matters more than volume.

The honest debate

What to watch next

Three things that resolve the debate
  • 1 · Citelum city lighting contract wins in Q3–Q4 FY27

    Pre-qualified team and active bidding underway for Tata, Mahindra, and SEZ projects. If Citelum wins material tenders, it validates the ₹300–350 Cr, 3–4 year thesis and signals margin recovery on higher-margin technical/O&M contracts.

  • 2 · Waste management TPD scaling to 600–800 TPD in H2 FY27

    Currently 400 TPD with active bidding for larger capacity. Waste management is higher-margin than government staffing contracts. TPD ramp-up signals operational leverage recovery and validates new-vertical strategy.

  • 3 · Q3 FY27 employee cost % revenue (target: sub-78%)

    The single number that settles the debate. If employee costs normalize back toward 75% in Q3 (new contracts streamlining), margin recovery narrative is intact. If they stay at 79%+ (contracts not streamlining as fast), the bear case is in force.

The verdict

Krystal delivered a quarter of strong operational execution (46% revenue growth, 59 new corporates, robust order book) but weak profitability leverage (margin compression, elevated employee costs). The stock price reflects this tension—up from lows but down from highs, caught between growth optimism and margin doubt.

This is not a step-change quarter; it's a continuation of a strategic bet on corporate segment expansion and new verticals. That bet is right, but it requires near-term margin tolerance. If Citelum, waste management, and corporate O&M contracts become material revenue streams with better margins, then PAT will re-accelerate. If those bets disappoint, PAT growth will stay muted relative to revenue, and the valuation multiple will stay compressed.

For holders, the number to track is employee cost % of revenue. It's the leading indicator of whether margin recovery is real or deferred. Watch for it to trend back toward 75% by Q4 FY27; if it stays elevated, the margin headwind is structural—and the re-rating thesis breaks.

Rating: Hold. Growth is real, but profitability trajectory is in question. Wait for Q3 margin data to reassess.

Single number to track: Employee cost % revenue. Recovery path becomes clear only when this normalizes.

Informational and educational content only. Not investment advice.